Effects of membrane and soluble EPCR on the hemostatic balance and endotoxemia in mice.

Recent studies have shown that endothelial protein C receptor (EPCR) polymorphisms and soluble EPCR levels are associated with thrombotic diseases. It is unknown whether membrane EPCR (mEPCR) heterozygosity and/or physiologically elevated sEPCR levels directly impact the hemostatic balance and the outcome of endotoxemia. In these studies, thrombin infusion experiments revealed that EPCR heterozygosity (Procr+/-) impaired protein C activation by approximately 30%. Infusion of factor Xa with phospholipid demonstrated that the Procr+/- genotype increased the coagulant response relative to wild-type mice. Challenge of the Procr+/- mice with lipopolysaccharide (LPS) did not significantly exaggerate their response compared with wild-type mice. We also generated mice in which one allele of full-length EPCR was replaced by sEPCR (Procrs/+). Compared with Procr+/- mice, Procrs/+ mice had 5-fold higher sEPCR and similar mEPCR levels. Procr+/- and Procrs/+ mice generated similar levels of activated protein C (APC) upon thrombin infusion. They also exhibited a similar coagulant response upon factor Xa/phospholipid infusion. Only supraphysiologic levels of sEPCR could influence protein C activation and exaggerate the coagulant response. In conclusion, mEPCR, but not physiologically elevated sEPCR, regulated protein C activation. Procr heterozygosity results in a mild increase of thrombosis tendency and little influence on the response to endotoxin.

[1]  José A Fernández,et al.  Anticoagulant protein C pathway defective in majority of thrombophilic patients. , 1993 .

[2]  E. Rosen,et al.  Mice with a Severe Deficiency of the Endothelial Protein C Receptor Gene Develop, Survive, and Reproduce Normally, and Do not Present with Enhanced Arterial Thrombosis after Challenge , 2002, Thrombosis and Haemostasis.

[3]  J. Ganopolsky,et al.  A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model. , 2004, The American journal of pathology.

[4]  C. Esmon,et al.  Proteinase-3 and CD 11 b / CD 18 Binds to Activated Neutrophils : Involvement The Soluble Endothelial Protein C Receptor , 2000 .

[5]  J. Gris,et al.  Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death. , 2004, Blood.

[6]  C. Esmon,et al.  Extraembryonic expression of EPCR is essential for embryonic viability. , 2005, Blood.

[7]  C. Esmon,et al.  Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. , 1997, Circulation.

[8]  G Leone,et al.  The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. , 1999, The New England journal of medicine.

[9]  T. Koyama,et al.  Plasma Levels of Endothelial Cell Protein C Receptor Are Elevated in Patients With Sepsis and Systemic Lupus Erythematosus : Lack of Correlation With Thrombomodulin Suggests Involvement of Different Pathological Processes , 1998 .

[10]  D. Ginsburg,et al.  Prothrombotic phenotype of protein Z deficiency. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Esmon,et al.  Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin , 2005, Journal of thrombosis and haemostasis : JTH.

[12]  R. Westrick,et al.  Lethal Perinatal Thrombosis in Mice Resulting From the Interaction of Tissue Factor Pathway Inhibitor Deficiency and Factor V Leiden , 2002, Circulation.

[13]  Jeffrey I. Weitz,et al.  Characterization of a Mouse Model for Thrombomodulin Deficiency , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[14]  A. Chang,et al.  Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. , 1987, The Journal of clinical investigation.

[15]  F. Castellino,et al.  A cardioprotective role for the endothelial protein C receptor in lipopolysaccharide-induced endotoxemia in the mouse. , 2005, Blood.

[16]  C. Esmon,et al.  Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo. , 2000, Blood.

[17]  Jerry A Nick,et al.  Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. , 2004, Blood.

[18]  C. Esmon.  Regulation of blood coagulation. , 2000, Biochimica et biophysica acta.

[19]  C. Esmon,et al.  Disruption of the Endothelial Cell Protein C Receptor Gene in Mice Causes Placental Thrombosis and Early Embryonic Lethality* , 2002, The Journal of Biological Chemistry.

[20]  C. Esmon,et al.  The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J S Yudkin,et al.  EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro. , 2005, Atherosclerosis.

[22]  C. Esmon,et al.  The Ser219–>Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype , 2006, Journal of thrombosis and haemostasis : JTH.

[23]  C. Esmon,et al.  Mechanisms by Which Soluble Endothelial Cell Protein C Receptor Modulates Protein C and Activated Protein C Function* , 2000, The Journal of Biological Chemistry.

[24]  Naomi,et al.  On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. , 1995, The Journal of clinical investigation.

[25]  F R Rosendaal,et al.  Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis , 2004, Journal of thrombosis and haemostasis : JTH.

[26]  Philippe Soriano,et al.  Epiblast‐restricted Cre expression in MORE mice: A tool to distinguish embryonic vs. extra‐embryonic gene function , 2000, Genesis.

[27]  J. Reny,et al.  A HAPLOTYPE OF THE EPCR GENE IS ASSOCIATED WITH INCREASED PLASMA LEVELS OF sEPCR AND IS A CANDIDATE RISK FACTOR FOR THROMBOSIS Short title : EPCR gene , sEPCR level and thrombotic , 2003 .

[28]  J. Helterbrand,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis , 2003 .

[29]  Justo Aznar,et al.  Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk , 2004, Thrombosis and Haemostasis.

[30]  C. Esmon,et al.  Antibodies to thrombomodulin are found in patients with lupus anticoagulant and unexplained thrombosis. , 2000, The Journal of rheumatology.

[31]  C. Esmon,et al.  Identification of functional endothelial protein C receptor in human plasma. , 1997, The Journal of clinical investigation.

[32]  P. Carmeliet,et al.  Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice. , 2003, Blood.

[33]  C. Esmon,et al.  Metalloproteolytic Release of Endothelial Cell Protein C Receptor* , 2000, The Journal of Biological Chemistry.

[34]  P. Mannucci,et al.  Autoantibodies against the endothelial receptor of protein C are associated with acute myocardial infarction in young women , 2005, Journal of thrombosis and haemostasis : JTH.

[35]  M. Loeb,et al.  Patients with severe sepsis vary markedly in their ability to generate activated protein C. , 2004, Blood.

[36]  W. Ruf,et al.  Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.